Headline
The latest stories from AHA Today.
The National Center for Healthcare Leadership is accepting nominations through June 8 for the 2018 Gail L. Warden Leadership Excellence Award.
The Senate Finance Committee today held a hearing on “Rural Health Care in America: Challenges and Opportunities.”
The Senate Judiciary Committee today approved five bills to address the opioid crisis, which include provisions aimed at increasing participation in drug take-back programs, strengthening Drug Enforcement Administration discretion in setting opioid quotas, and reducing demand for illicit narcotics.
The AHA today submitted comments on the Food and Drug Administration’s Medical Device Safety Action Plan.
The Senate Finance Committee yesterday introduced 22 bipartisan bills to address the opioid crisis in Medicare, Medicaid and human services programs.
The House Energy and Commerce Subcommittee on Health yesterday held a hearing on bipartisan legislation that would reauthorize the Children’s Hospitals Graduate Medical Education Program through 2023 at $330 million a year, $30 million more than the current funding level.
The Comprehensive Primary Care Initiative reduced hospitalizations and emergency department visits and improved primary care delivery for beneficiaries, but did not reduce Medicare spending enough to cover care management fees or significantly improve quality.
The AHA today named as its senior vice president for field engagement C. Douglas Shaw, currently chief operating and development officer for the association’s Health Forum subsidiary.
The Senate Health, Education, Labor and Pensions Committee today voted 22-1 to approve the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.
The Food and Drug Administration has approved special handling instructions to allow health care providers to use certain opioid and other intravenous drug products made by Hospira that were on hold due to low potential for a manufacturing defect but are in short supply.